Literature DB >> 1961614

Tissue plasminogen activating factor assisted removal of subretinal hemorrhage.

G A Peyman1, N C Nelson, W Alturki, K J Blinder, C L Paris, U R Desai, C A Harper.   

Abstract

We used tissue plasminogen activator (tPA) to aid in the surgical evacuation of subretinal hemorrhages. Subretinal hemorrhage secondary to a ruptured retinal macroaneurysm was treated in two patients. The surgical technique involved using a micropipette to fashion a small retinotomy through which tPA was injected into the subretinal space and through which the dissolved clot was removed. Visual acuity improved from counts fingers to 20/50 in one patient and from counts fingers to 20/70 in the other. Three additional patients, with massive subretinal hemorrhages secondary to age-related macular degeneration, were similarly treated. In one, visual acuity improved from counts fingers to 20/400; in two others, visual acuity was stabilized; in the first patient, at 20/300, and in the second patient at 20/400. The use of tPA minimizes surgical manipulation of the sensory retina and greatly reduces the size of the retinotomy required for evacuation of subretinal blood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961614

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  24 in total

1.  Scanning and transmission electron microscopic findings during RPE wound healing in vivo.

Authors:  A Oganesian; E Bueno; Q Yan; C Spee; J Black; N A Rao; P F Lopez
Journal:  Int Ophthalmol       Date:  1997       Impact factor: 2.031

2.  Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.

Authors:  Jost Hillenkamp; Vladimir Surguch; Carsten Framme; Veit-Peter Gabel; Helmut G Sachs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-11       Impact factor: 3.117

3.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

4.  The use of tissue plasminogen activator in post-traumatic total hyphaema.

Authors:  L Laatikainen; J Mattila
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-01       Impact factor: 3.117

5.  Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.

Authors:  Makoto Inoue; Fumio Shiraga; Yukari Shirakata; Yuki Morizane; Shuhei Kimura; Akito Hirakata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-25       Impact factor: 3.117

6.  Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.

Authors:  Luis Arias; Jordi Monés
Journal:  Clin Ophthalmol       Date:  2010-02-18

7.  Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator.

Authors:  R P Singh; C Patel; J E Sears
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

8.  Management of postvitrectomy diabetic vitreous hemorrhage with volume homeostatic fluid-fluid exchanger.

Authors:  Wen-Chuan Wu; Jen-Yu Chen; Ya-Chi Chen; Yo-Chen Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-07       Impact factor: 3.117

9.  Recombinant tissue plasminogen activator, vitrectomy, and gas for recent submacular hemorrhage displacement due to retinal macroaneurysm.

Authors:  Elsbeth J T van Zeeburg; Matteo G Cereda; Jan C van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

10.  Retinal Arterial Macroaneurysms: Updating your Memory on RAM Management.

Authors:  Brian Evan Goldhagen; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2019-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.